HIV-associated Tuberculosis
1 clinical trials · Condition
◉ Watch HIV-associated Tuberculosis
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis (NCT05630872) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-02-13 |
Track HIV-associated Tuberculosis automatically
Every clearance here is in the API, with alerts when new ones post.